Table 1. Backgrounds of patients.
| Lusutrombopag group (n = 25) | Cirrhotic group (n = 128) | P value | |
|---|---|---|---|
| Age (years) | 67±8.4 | 72±3.2 | 0.47 |
| Male/Female | 21/4 | 89/39 | 0.22 |
| Etiology (HBV/HCV/Alcohol/NASH/others) | 1/14/8/2/0 | 10/83/17/11/7 | 0.20 |
|
Invasive procedure (RFA/TACE/EIS/EVL/PSE) |
10/3/6/5/1 | 45/45/21/17/0 | 0.05 |
| Albumin (g/dl) | 3.5±0.47 | 3.2±0.57 | 0.06 |
| ALT (IU/ml) | 56±42 | 50±40 | 0.54 |
| Total bilirubin (g/dl) | 1.4±0.67 | 1.6±0.88 | 0.25 |
| Platelet (×104/μl) | 3.9±1.3 | 3.9±0.75 | 0.34 |
| Child-Pugh score 5/6/7/8≦ | 7/13/2/3 | 23/78/15/12 | 0.69 |
Values are mean ± standard deviation. NASH;nonalcoholic steatohepatitis, ALT; alanine aminotransferase, RFA;radiofrequency ablation, TACE;transarterial chemoembolization, EIS;endoscopic injection sclerotherapy, EVL;endoscopic variceal ligation, PSE;partial splenic embolization.